SEP 13 - 14 2017 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Microbiology & Immunology 2017
12 76 5749

Welcome to the LabRoots Microbiology & Immunology 2017 Virtual Conference! Join us in bringing the Microbiology research community together online in discovering new concepts, tools and techniques to apply to ongoing research and diagnostics. This conference is free to attend.

Microbiology and Immunology cover an immense scope, encompassing various industries and research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about. Being able to explore this biodiversity and use new knowledge for drug discovery and biotechnology applications is an exciting and expanding area of research.

With progress made toward learning more about the world of microbiology and disease, the need for more rapid diagnosis, increased standardization of testing and greater adaptability to manage threats from newly evolved infectious microorganisms will become more and more apparent. The combination of the new tools being developed along with advancements in basic knowledge can lead to profound changes and growth in Microbiology and Immunology.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
 

Topics for this years virtual conference include:

  • Virology
  • Antimicrobial
  • Food Microbiology
  • Beneficial Microbes
  • Polymicrobial
  • Microbiology of the Household Environment


Continuing Education

By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

 Use #LRmicro to follow the conversation!
 


Speakers:
  • Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
  • Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
  • Vice President of Precision Oncology, Vela Dx
  • Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
  • Postdoctoral Research Scholar , Washington University School of Medicine
  • Professor, Applied Ecology, NC State University
  • Science Communications Manager, Innovative Genomics Institute
  • Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
  • Associate Professor, Department of Biology, Purdue University
  • Professor, Department of Plant Pathology, University of Kentucky
  • Research Fellow, University of Birmingham
  • Senior Scientist, Microbial Genomics, QIAGEN
  • Associate Professor , North Carolina State University
  • Instructor, Pathology & Immunology, Baylor College of Medicine
  • Professor, Institute of Plant Science and Resources, Okayama University
  • Professor Emeritus, West Virginia University School of Medicine
  • Consultant Medical Microbiologist

Show Resources
Agenda
All times are Pacific Time
  • SEP 13, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Microbe Wars: The Rise of CRISPR Immunity and Technology
    Speaker: Megan Hochstrasser, PhD
  • SEP 13, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria
    Speaker: Paul Turner, PhD
  • SEP 13, 2017 01:30 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The escalating challenges of antimicrobial resistance and the efforts to conquer these threats
    Speaker: Glenn Tillotson, PhD, FIDSA, FCCP
  • SEP 14, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A neo-virus lifestyle exhibited by a (+)ssRNA virus hosted in an unrelated dsRNA virus: taxonomic and evolutionary considerations
    Speaker: Nobuhiro Suzuki, PhD
  • SEP 14, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    BENEFICIAL MICROBES: Sharing of the Microbial Informational Library
    Speaker: John Thomas, PhD
  • SEP 14, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance
  • SEP 14, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Development of tools enabling tunable, in situ delivery of therapeutics using probiotics
    Speaker: Nathan Crook
  • SEP 14, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Sex as a Biological Variable in Microbial Pathogenesis
    Speaker: Sabra Klein, PhD
  • SEP 14, 2017 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Real-time pathogen surveillance systems using nanopore sequencing
  • SEP 14, 2017 01:30 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dissecting the ecological and molecular mechanisms underlying the interaction between plant viruses and their insect vectors
    Speaker: Punya Nachappa, PhD
  • Virology
  • SEP 13, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Microbe Wars: The Rise of CRISPR Immunity and Technology
    Speaker: Megan Hochstrasser, PhD
  • SEP 13, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria
    Speaker: Paul Turner, PhD
  • SEP 14, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    A neo-virus lifestyle exhibited by a (+)ssRNA virus hosted in an unrelated dsRNA virus: taxonomic and evolutionary considerations
    Speaker: Nobuhiro Suzuki, PhD
  • SEP 14, 2017 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Real-time pathogen surveillance systems using nanopore sequencing
  • SEP 14, 2017 01:30 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dissecting the ecological and molecular mechanisms underlying the interaction between plant viruses and their insect vectors
    Speaker: Punya Nachappa, PhD
  • Antimicrobial
  • SEP 13, 2017 01:30 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The escalating challenges of antimicrobial resistance and the efforts to conquer these threats
    Speaker: Glenn Tillotson, PhD, FIDSA, FCCP
  • SEP 14, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance
  • SEP 14, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Sex as a Biological Variable in Microbial Pathogenesis
    Speaker: Sabra Klein, PhD
  • Beneficial Microbes
  • SEP 14, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    BENEFICIAL MICROBES: Sharing of the Microbial Informational Library
    Speaker: John Thomas, PhD
  • SEP 14, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Development of tools enabling tunable, in situ delivery of therapeutics using probiotics
    Speaker: Nathan Crook
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Paul Turner, PhD
    Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
    Biography
      Paul Turner is the Elihu Professor of Ecology and Evolutionary Biology at Yale University, where he has served as Interim Dean of Science and Departmental Chair. He is also a faculty member in Microbiology at Yale University School of Medicine. Dr. Turner's research interests include: evolutionary biology, evolutionary medicine, infectious disease, microbiology, phage therapy, RNA viruses, vector-borne disease, and virology. He uses an interdisciplinary approach in his research laboratory, employing techniques from microbiology, population genetics, genomics, molecular biology and mathematical modeling to study hypotheses in ecology and evolutionary biology. Paul Turner received his Ph.D. from the Center for Microbial Ecology at Michigan State University. He then conducted postdoctoral work at University of Maryland College Park, University of Valencia in Spain, and the National Institutes of Health. He regularly serves on committees for the National Science Foundation, National Institutes of Health and the American Society for Microbiology. He was elected chair of international meetings, such as the 2013 Gordon Research Conference on Microbial Population Biology, and the 2018 Jacques Monod Conference on Viral Emergence. He has authored nearly 100 scholarly journal articles, reviews and book chapters.
    • Neil Osheroff, PhD
      Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
      Biography
        Neil Osheroff received a Bachelor's Degree in Chemistry from Hobart College in 1974 followed by a Ph.D. in Biochemistry and Molecular Biology from Northwestern University in 1979. His doctoral dissertation on the mechanism of action of cytochrome c was under the direction of Professor Emanuel Margoliash. Following his doctoral studies, Dr. Osheroff moved to the Stanford University School of Medicine in 1980, where he was a Helen Hay Whitney Foundation postdoctoral fellow with Dr. Douglas Brutlag in the Department of Biochemistry. In 1983, he moved to the Vanderbilt University School of Medicine as an Assistant Professor of Biochemistry and he has been on the faculty since that time. Dr. Osheroff currently holds Professorships in the Departments of Biochemistry and Medicine and was endowed with the John G. Coniglio Chair in Biochemistry in 2003. He has spent a combined 27 years on the editorial boards of The Journal of Biological Chemistry and Biochemistry and has authored over 240 publications. Dr. Osheroff's research focuses on topoisomerases, enzymes that remove knots and tangles from the genetic material and modulate torsional stress in DNA. In addition to their critical physiological roles, human type I and II topoisomerases are the targets for a number of widely used anticancer drugs. Furthermore, bacterial type II topoisomerases are the targets for quinolones, a drug class that includes some of the most frequently prescribed antibacterials in the world. The Osheroff laboratory has made seminal contributions to our understanding of how topoisomerases function and how anticancer drugs, natural products, and antibacterials interact with these enzymes and alter their catalytic functions. Beyond his research, Dr. Osheroff has a long-standing interest in mentoring and training young scientists and physicians. Twenty-seven Ph.D. students have graduated under his mentorship. Dr. Osheroff he has been a course director since 1990 and holds a number of educational leadership positions in the Vanderbilt University School of Medicine. Dr. Osheroff Chaired the NCI-I "Transition to Independence" study section from 2013-2016 and has held leadership positions in two international medical science educator organizations. Finally, Dr. Osheroff has received awards for mentoring, teaching, curricular design, educational service, and affirmative action and diversity. Over the past five years, he has been invited to present more than seventy scientific and educational talks at forty-six institutions/meetings in seventeen different countries.
      • Condie Carmack, PhD
        Vice President of Precision Oncology, Vela Dx
        Biography
          Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
        • Charles Chiu, MD, PhD
          Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
          Biography
            Dr. Charles Chiu, M.D./Ph.D., is an Assistant Professor in Laboratory Medicine and Medicine, Infectious Diseases at the University of California, San Francisco. He is also the Director of UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) at China Basin and Associate Director of the UCSF Clinical Microbiology Laboratory. Charles is an expert in the emerging field of viral metagenomics, and his research is focused on the development of microarray and deep sequencing technologies for viral pathogen discovery and clinical diagnostics. He is also the principal investigator on an R01 grant from the NIH on blood bank pathogen screening, California Discovery, UC-MEXUS, and National Research Fund for Tickborne Diseases (NRFTD) grants on the microbial epidemiology of encephalitis, diarrhea, and Lyme disease, a QB3 Rogers Family Foundation Award in translational diagnostics, and a UCSF-Abbott Viral Discovery Award. Charles has more than 30 patents and peer-reviewed publications in scientific journals and ongoing collaborations with research groups and public health agencies worldwide, including Abbott Diagnostics, Inc., Global Viral Forecasting, the United States CDC, the American Red Cross, and the Texas Biomedical Research Institute.
          • Nathan Crook
            Postdoctoral Research Scholar , Washington University School of Medicine
            Biography
              Nathan Crook is a postdoctoral researcher in the Department of Pathology & Immunology at Washington University School of Medicine in the laboratory of Prof. Gautam Dantas, where he is applying functional metagenomics and next-generation sequencing to improve control over colonization and gene expression in probiotic bacteria. Nathan received his B.S. in Chemical Engineering from the California Institute of Technology in 2009, and his PhD in Chemical Engineering from the University of Texas at Austin in 2014. During his graduate work in the Alper Lab, Nathan developed several high-throughput computational and experimental methods which accelerate the engineering of new industrial phenotypes in S. cerevisiae. In the future, Nathan aims to engineer probiotics for in situ synthesis and delivery of therapeutics. Nathan has published 10 papers relating to his work, in addition to 2 book chapters and 3 review articles. He has mentored 2 high school students, 6 undergraduates, and 4 graduate students in experimental synthetic biology research. Nathan received the National Science Foundation's Graduate Research Fellowship in 2010.
            • Rob Dunn, PhD
              Professor, Applied Ecology, NC State University
            • Megan Hochstrasser, PhD
              Science Communications Manager, Innovative Genomics Institute
              Biography
                Megan has a B.A. in Biology from Brown University and received her Ph.D. from Jennifer Doudna's lab at UC Berkeley in 2016, where she studied mechanisms of CRISPR immunity in bacteria. She joined the IGI in September 2016 to handle scientific communications, hoping to bridge the gap between researchers and the public.
              • Sabra Klein, PhD
                Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
              • Punya Nachappa, PhD
                Associate Professor, Department of Biology, Purdue University
                Biography
                  Dr. Punya Nachappa Ph.D., is an Associate Professor in the Department of Biology at Purdue University, Fort Wayne. With a background in agriculture, specializing in entomology, Dr. Nachappa studies insects that transmit microbes or pathogens that causes diseases in plants such as soybeans. During her first year at Purdue, a new soybean virus was discovered which has become a big focus of her research. When trying to study the interaction between the virus, its insect vector and the host plant Dr. Nachappa and her students found that insects carrying the virus have better reproduction rates than insects who do not. Understanding the interaction between the insect and virus, and what it means to growers, is the focus for the future. Dr. Nachappa has more than 15 peer-reviewed publications in scientific journals and over a million dollar in funding from federal and regional agencies such as USDA and Indiana Soybean Alliance, respectively. She has presented her research at several top-tier universities, regional and national conferences. She has served as peer-reviewer for 20 international journals and ad-hoc reviewer for 4 national and international funding organizations including panel member for USDA.
                • Peter Nagy
                  Professor, Department of Plant Pathology, University of Kentucky
                • Josh Quick
                  Research Fellow, University of Birmingham
                  Biography
                    Josh is a molecular biologist finishing up his PhD at the University of Birmingham. He is a member of Nick Loman's lab which explores the use of cutting-edge genomics and metagenomics approaches to the diagnosis, treatment and surveillance of infectious disease. In 2015 during the West-African Ebola virus outbreak he travelled to Guinea with a 'lab-in-a-suitcase' to establish a sequencing laboratory to perform genome sequencing of new cases in a matter of days. Last year, over the course of three trips to Brazil, he developed a multiplex version of the tiling-amplicon approach used previously leading to the first successful sequencing of Zika virus genomes directly from clinical samples. This was successfully used by the ZiBRA consortium and other groups investigating the origins of Zika virus in the Americas. Most recently, as part of a group of developers known as the Nanopore WGS consortium, he showed it was possible to sequence extremely long reads on the MinION using optimized extraction and rapid sequencing protocols. Generating runs with read N50's over 100 kilobases it demonstrated MinION is likely to be the platform of choice for those seeking highly contiguous assemblies for complex genomes.
                  • Winnie Ridderberg
                    Senior Scientist, Microbial Genomics, QIAGEN
                    Biography
                      Winnie Ridderberg, a microbiologist, received her doctoral degree from Aarhus University, Denmark. Winnie has almost a decade's experience in clinical microbiology, from working at the Department of Clinical Microbiology at Aarhus University Hospital. Winnie's primary research interest has been the microbiology of cystic fibrosis with specific focus on bacterial evolution and microbiome studies. Winnie joined QIAGEN Bioinformatics in early 2017 as a research scientist at the Microbial Genomics team.
                    • Dorith Rotenberg
                      Associate Professor , North Carolina State University
                    • Jennifer Spinler, PhD
                      Instructor, Pathology & Immunology, Baylor College of Medicine
                      Biography
                        Dr. Spinler is an experienced classical microbiologist with extensive training in bacterial genetics and genomics currently serving as faculty at Baylor College of Medicine in the Texas Children's Microbiome Center. Her expertise in developing mutagenesis systems for investigations of gram-positive bacteria which has contributed to recent successes with genetics of probiotics; particularly in the area of antimicrobial production by Lactobacillus reuteri. Current research efforts combine comparative and functional genomics strategies with animal models and microbiome research to understand how individual probiotic organisms beneficially impact the larger microbiome community of the gastrointestinal tract and how these interactions protect against antibiotic-associated disease. Specifically, her research is aimed at developing adjunct probiotic therapies targeting C. difficile infection. As a probiotic researcher in a hospital-based microbiome center, Dr. Spinler has the benefit of combining her expertise with clinically relevant microbiome studies which has tremendous potential to impact our basic understanding of mechanisms of bacterial resistance and create new translational opportunities combatting antimicrobial resistance.
                      • Nobuhiro Suzuki, PhD
                        Professor, Institute of Plant Science and Resources, Okayama University
                        Biography
                          Nobuhiro SUZUKI serves as a full professor of the Institute of Plant Stress and Resources, formerly Research Institute for Bioresouces at Okayama University and Editors for the plant and fungal virus section of Virus Research, Frontiers in Virology and the Journal of General Plant Pathology. He has been Guest Editors to PLoS Pathogens, PNAS, and mBio, and Board Members of Virology and Journal of Virology. Currently he is working on virus/host interactions using several different pathosystems involving fungal and plant viruses. Prior to coming to Kurashiki, Okayama Prefecture, he was a visiting fellow of the Center for Agricultural Biotechnology at the University of Maryland Biotechnology Institute for four years (1997-2001) to study molecular biology of hypoviruses in the laboratory of Professor Donald L. Nuss. Before visiting UMBI, he served as an assistant professor and a lecturer of the Biotechnology Institute at the Akita Prefectural College of Agriculture for 11 years (1988-1998) where he conducted a project on molecular characterization of rice dwarf phytoreovirus, a member of the family Reoviridae. He received awards from the Japanese Phytopathological Society of Japan and Japanese Society for Virology for his outstanding achievements in plant virology. Dr Suzuki received his M. S. (1985) in phytopathology and Ph. D (1989) in virology from Tohoku University in Sendai, Japan.
                        • John Thomas, PhD
                          Professor Emeritus, West Virginia University School of Medicine
                          Biography
                            Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " (www.globalbugs.com) having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and Graduate School Education (Adjunct Professor) for 54 years , his research emphasizing biofilms and medical devices. He has recently focused upon micro 3-D- bio Printing of contour fitting gauzes using bio-plastics and unique Prebiotics with Therapeutic Bacteria (Beneficial Bacteria) for chronic wound intervention (SMarT Gauze); this integrates a common pathway, visualized through his 'Microbial Clock' and recently created Center of Hologenomic Clinical Studies (www.globalbugs.com/Hologenomic Center) which underscores a "Dual Citizenship" and co evolution of symbiotic microbes and human ecosystems. "Microbes Matter". His Probiotic Solutions integrates Computer Decision Support for Probiotic (Beneficial Bacteria) Guidelines combining AI, Artificial Intelligence and Precision Medicine, expanded recently to emphasize Chronic Wound Care and Aging, hypothesized now as a disease. He has over 50 publications, multiple book chapters and significant grant support. His military obligation (1969-71)(wounds) and his sabbatical at Cardiff University, Wales, UK (2007)(oral health, biofilms) have remained a driving catalyst. He has been a member of the American Dental Association Scientific Advisory Committee for the last 8 years and American Society of Microbiology for 54 years. As Faculty at 3 national (Northeastern Ohio Universities College of Medicine, Rutgers University and West Virginia University) and 2 international Universities ( National University of Singapore and Cardiff University) during his career , he has received multiple Alumni and University awards for research and Student Mentoring ; retiring from West Virginia University in 2013 after 23 years as Professor Emeritus , he presently is expanding his research/teaching utilizing the advanced resources of the Allegheny Health Network (Center of Excellence in Biofilm Research) and Carnegie -Mellon University, Pittsburg, PA, and Mass. Gen. Hospital (Dept. of Anesthesia and Critical Care) with Harvard University, Boston, MA, all under the umbrella of his Global Microbiology Consulting. (GMC) (www.globalbugs.com)
                          • Glenn Tillotson, PhD, FIDSA, FCCP
                            Consultant Medical Microbiologist
                            Biography
                              Glenn Tillotson has 30+ years pharmaceutical experience in early pre-clinical and clinical research, commercialization, medical affairs, scientific communications including publication planning strategic drug development, life cycle management and global launch programs. Dr Tillotson has been instrumental in the development and launch of ciprofloxacin, moxifloxacin, gemifloxacin, fidaxomicin and most recently solithromycin. Glenn has held several key committee positions at the American College of Chest Physicians, he is on the Scientific Steering Committee for the GTCBio the Annual Summit on Anti-infective Partnering. Currently Dr Tillotson has published >150 peer-reviewed manuscripts, presented >270 scientific posters and is on several journal Editorial Advisory Boards including the Lancet Infectious Disease, eBioMedicine Expert Reviews in Anti-Infective Therapy and F1000.
                            Sponsored By

                            For information on becoming a sponsor or exhibitor, please click here.


                            Continuing Education (CME/CE/CEU) Credits

                            The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                            The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material is geared towards Primary Care Clinicians, All Health Care Professionals, Academia, and Industry. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Practice-Based Learning & Improvement.

                            Desired Outcomes

                            At the end of the activity, participants should be able to:

                            1. Demonstrate an understanding of the concept of the microbiome and its importance in human health
                            2. Identify routes of transmission of the microbiome to a human host
                            3. Integrate the provided content into practice in ways that are consistent with acknowledged practice guidelines and that improve patient management and outcomes
                            4. Utilize technologies currently available for use in the clinic and the limitations of these technologies
                            5. Cite current and established medical science principles and the application of these principles to patient care
                            6. Perform continuous self-assessment and learning to improve one’s professional and clinical practices, including how to interpret results in ways most useful to the patient

                            This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME® to provide continuing medical education for physicians.

                            CME Consultants designates each activity for the number of AMA PRA Category 1 CreditsTM listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                            (Internet) Live Activity, 5.0 AMA PRA Category 1 CreditsTM

                            (Internet Activity) Enduring Material, 5.0 AMA PRA Category 1 CreditsTM

                            --

                            Enduring Material Release date: 9/15/17

                            Enduring Material Termination date: 3/15/18

                             

                            In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.

                             


                            Committee

                            To download the Program Committee brochure here.


                            • Committee Chair: Tony Rook, MS

                              Tony A. Rook leads the Microbiology Resource Center at The Sherwin-Williams Company in Cleveland, OH, USA, where he has built a world-class Microbiology Center of Excellence to focus on global preservation strategies, continuous improvement of industrial hygiene practices, and ...

                              See more See less
                            • Emily Hollister, PhD

                              Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                              See more See less
                            • Marilyn Roossinck, PhD

                              Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...

                              See more See less
                            • Glenn Tillotson, SVP

                              Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications ...

                              See more See less
                            • Radhakrishna Tirumalai, PhD

                              Radhakrishna Tirumalai, PhD US Pharmacopeial Convention Dr. Tirumalai has been at the USP since 2003 and is currently a Principal Scientific Liaison in the Global Science and Standards Division. He is the Staff Liaison to the USP Expert Committees on Microbiology, and Toxicology ...

                              See more See less
                            • Ivan Brukner, PhD

                            • Philip Geis, PhD

                            Help

                            General LabRoots Questions

                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                            Contact us

                            Virtual Events and Webinars

                            Supported Configurations

                            • Operating System Internet Explorer Firefox Chrome Safari
                              Vista IE8+ FF10+ Chrome15+
                              Windows 7 IE8+ FF10+ Chrome15+
                              Windows 8 IE10 FF10+ Chrome15+
                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                            • Cookie settings: session cookies enabled
                            • Browser configuration must have JavaScript enabled
                            • Adobe Flash player 10.2 or later

                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                            Internet Connection

                            • A minimum of 100Kbps is recommended for audio-only events
                            • A minimum of 300Kbps is recommended for speaker on-video events

                            Computer Equipment

                            • Screen Resolution: Minimum 1024x768
                            • Video Card: 65,000 colors minimum
                            • Sound card and speakers (or headphones) for hearing webcast in full format
                            • Audio Card: 16-bit minimum
                            • RAM: 512MB of free RAM

                            Firewall Protocol

                            • HTTP on port 80 or HTTPS on port 443
                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                            Work-At-Home Attendees

                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                            For A Seamless Experience

                            When using a mobile device, FREE Mobile Apps are available:

                            - For viewing Webinars:

                            - For viewing Virtual Events

                            Attendee Guide

                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                            Virtual Event and Webinar Support:

                            Continuing Education (CME/CE) Support

                            Loading Comments...
                            Show Resources
                            Event Countdown
                            • 0 Days
                            • 0 Hours
                            • 0 Minutes
                            • 0 Seconds